Clinical Trial Signal Monitor $49
Watchlists

Build the feed you actually need.

Combine drugs, sponsors, conditions, NCT IDs, and ATC classes into custom watchlists. Daily source-backed briefs across registries, safety surveillance, literature, and disclosures — for what you care about.

Your watchlists

Free tier · 3 watchlists included
Watchlist Free slot 1 of 3
Add a watchlist
Mix drugs, sponsors, conditions, NCT IDs, or ATC classes.
Start with a single drug or sponsor. Add more entities later. Daily refresh on the source-backed signals that match.
Search to add →
Locked Pro · 50 trials
Follow trials on your desk
Pro · $199/month
Pro follows 50 trials and exports a CSV of your desk.
Unlock Pro

Watchlist templates

One tap to load a starting set
Therapeutic area

GLP-1 & obesity

Semaglutide, tirzepatide, retatrutide, orforglipron, plus Novo Nordisk, Eli Lilly, Roche, Pfizer obesity programs. Tracks trials, FDA mentions, FAERS trends, 8-K disclosures.
Load template →
Therapeutic area

Oncology checkpoint inhibitors

PD-1, PD-L1, CTLA-4, LAG-3, TIGIT, plus Merck, BMS, AstraZeneca, Regeneron programs. Trial movement, results, safety, EDGAR disclosure.
Load template →
Therapeutic area

Alzheimer's disease

Donanemab, lecanemab, anti-amyloid + anti-tau. Trial status, results posting, FDA advisory committee notices, safety surveillance.
Load template →
Modality

Rare-disease gene therapies

AAV-based programs, ex vivo gene-edited, in vivo CRISPR. Sarepta, BioMarin, Sangamo, CRISPR Therapeutics, Editas. Trial movement, safety, EDGAR.
Load template →
Operational

Public biotech trial delays

Cross-sponsor watch for Phase 2/3 primary-completion-date moves on listed biotech companies. Correlated with SEC EDGAR disclosures for investor signal.
Load template →
Custom

Build your own

Mix drugs, sponsors, conditions, NCT IDs. Daily brief. PDF / CSV export. Share with your team.
Unlock Pro

Paid desk

Monitor · $49/mo

Follow 25 trials

Desk stores current values and marks Changed when a field moves.
Choose Monitor
Pro · $199/mo

Follow 50 trials

CSV of your desk. PubMed, openFDA, and EU CTIS for followed trials.
Choose Pro
Watchlist briefs reflect public-record signals only. They do not include sponsor confidential pipeline information, investigator communications, or non-public data.